Brevan Howard Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $970K | Buy |
+29,177
| New | +$970K | 0.01% | 989 |
|
|
2025
Q1 | – | Sell |
-47,326
| Closed | -$1.56M | – | 1086 |
|
|
2024
Q4 | $1.56M | Buy |
47,326
+36,599
| +341% | +$1.2M | 0.01% | 302 |
|
|
2024
Q3 | $477K | Sell |
10,727
-3,102
| -22% | -$138K | ﹤0.01% | 638 |
|
|
2024
Q2 | $596K | Sell |
13,829
-2,507
| -15% | -$108K | 0.01% | 498 |
|
|
2024
Q1 | $478K | Sell |
16,336
-2,208
| -12% | -$64.6K | ﹤0.01% | 435 |
|
|
2023
Q4 | $413K | Buy |
+18,544
| New | +$413K | 0.01% | 522 |
|